Stock Analysis

Global Penny Stocks To Watch With Market Caps Under US$2B

SHSE:600226
Source: Shutterstock

Global markets have been experiencing a turbulent week, marked by geopolitical tensions and concerns over consumer spending, leading to declines in major indexes. In such uncertain times, investors often look for opportunities that balance affordability with potential growth. Penny stocks, though an outdated term, continue to represent smaller or newer companies that can offer surprising value when backed by strong financials.

Top 10 Penny Stocks Globally

NameShare PriceMarket CapFinancial Health Rating
DXN Holdings Bhd (KLSE:DXN)MYR0.51MYR2.54B★★★★★★
Datasonic Group Berhad (KLSE:DSONIC)MYR0.275MYR765.09M★★★★★★
Angler Gaming (NGM:ANGL)SEK3.92SEK293.94M★★★★★★
T.A.C. Consumer (SET:TACC)THB4.14THB2.48B★★★★★★
Foresight Group Holdings (LSE:FSG)£3.91£445.66M★★★★★★
Hil Industries Berhad (KLSE:HIL)MYR0.855MYR283.81M★★★★★★
Warpaint London (AIM:W7L)£3.58£289.22M★★★★★★
Bosideng International Holdings (SEHK:3998)HK$3.91HK$45B★★★★★★
Next 15 Group (AIM:NFG)£3.135£311.79M★★★★☆☆
SKP Resources Bhd (KLSE:SKPRES)MYR0.995MYR1.55B★★★★★☆

Click here to see the full list of 5,705 stocks from our Global Penny Stocks screener.

Let's review some notable picks from our screened stocks.

Zhejiang Hengtong HoldingLtd (SHSE:600226)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Zhejiang Hengtong Holding Co., Ltd. engages in the research, development, production, and sale of biological pesticides, veterinary drugs, and animal feed additives both in China and internationally with a market capitalization of approximately CN¥8.57 billion.

Operations: Zhejiang Hengtong Holding Co., Ltd. does not report specific revenue segments.

Market Cap: CN¥8.57B

Zhejiang Hengtong Holding Co., Ltd. demonstrates strong financial health with short-term assets of CN¥1.5 billion exceeding both its short-term and long-term liabilities, indicating robust liquidity. The company has a solid earnings growth trajectory, with profits increasing by 94.2% over the past year, surpassing industry averages significantly. Despite a low Return on Equity at 4.6%, the company's high-quality earnings and stable weekly volatility suggest resilience in volatile markets. However, negative operating cash flow raises concerns about debt coverage, and an inexperienced board may impact strategic direction amidst recent shareholder meetings signaling potential governance changes.

SHSE:600226 Debt to Equity History and Analysis as at Feb 2025
SHSE:600226 Debt to Equity History and Analysis as at Feb 2025

V V Food & BeverageLtd (SHSE:600300)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: V V Food & Beverage Co., Ltd is involved in the research, development, production, and sale of food and beverage products both in China and internationally with a market cap of CN¥5.27 billion.

Operations: No specific revenue segments are reported for V V Food & Beverage Co., Ltd.

Market Cap: CN¥5.27B

V V Food & Beverage Co., Ltd. shows a promising financial profile with its debt to equity ratio significantly reduced from 131.4% to 10.5% over five years, and interest payments well covered by EBIT at 95.7 times, indicating strong debt management. The company's short-term assets of CN¥1.8 billion comfortably cover both short and long-term liabilities, reflecting solid liquidity. Despite a low Return on Equity of 9.5%, earnings have grown impressively by 146% in the past year, surpassing industry averages and supported by improved profit margins from 3.1% to 9.5%. However, large one-off gains impact earnings quality, and dividends remain unsustainable due to insufficient free cash flows despite having more cash than total debt.

SHSE:600300 Debt to Equity History and Analysis as at Feb 2025
SHSE:600300 Debt to Equity History and Analysis as at Feb 2025

Hainan RuiZe New Building MaterialLtd (SZSE:002596)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Hainan RuiZe New Building Material Co., Ltd operates in China, producing and selling commercial concrete and cement, with a market cap of CN¥4.02 billion.

Operations: The company generates its revenue of CN¥1.52 billion entirely from its operations in China.

Market Cap: CN¥4.02B

Hainan RuiZe New Building Material Co., Ltd. faces challenges with profitability, as it remains unprofitable with declining earnings over the past five years at a rate of 16.7% annually. Despite this, the company maintains a solid cash runway exceeding three years due to positive free cash flow growth of 17.3% per year. Short-term assets (CN¥2.7 billion) comfortably cover both short and long-term liabilities, indicating sound liquidity management despite a high net debt to equity ratio of 135.5%. The board and management are experienced, though share price volatility remains high over recent months.

SZSE:002596 Financial Position Analysis as at Feb 2025
SZSE:002596 Financial Position Analysis as at Feb 2025

Make It Happen

Want To Explore Some Alternatives?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Zhejiang Hengtong HoldingLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SHSE:600226

Zhejiang Hengtong HoldingLtd

Researches and develops, produces, and sells biological pesticides, veterinary drugs, and animal feed additive products in People's Republic of China and internationally.

Solid track record with adequate balance sheet.